| Literature DB >> 25965334 |
Mandy Muller1, Stephanie Hutin1, Oliver Marigold1, Kathy H Li2, Al Burlingame2, Britt A Glaunsinger3.
Abstract
During lytic Kaposi's sarcoma-associated herpesvirus (KSHV) infection, the viral endonuclease SOX promotes widespread degradation of cytoplasmic messenger RNA (mRNA). However, select mRNAs escape SOX-induced cleavage and remain robustly expressed. Prominent among these is interleukin-6 (IL-6), a growth factor important for survival of KSHV infected B cells. IL-6 escape is notable because it contains a sequence within its 3' untranslated region (UTR) that can confer protection when transferred to a SOX-targeted mRNA, and thus overrides the endonuclease targeting mechanism. Here, we pursued how this protective RNA element functions to maintain mRNA stability. Using affinity purification and mass spectrometry, we identified a set of proteins that associate specifically with the protective element. Although multiple proteins contributed to the escape mechanism, depletion of nucleolin (NCL) most severely impacted protection. NCL was re-localized out of the nucleolus during lytic KSHV infection, and its presence in the cytoplasm was required for protection. After loading onto the IL-6 3' UTR, NCL differentially bound to the translation initiation factor eIF4H. Disrupting this interaction, or depleting eIF4H, reinstated SOX targeting of the RNA, suggesting that interactions between proteins bound to distant regions of the mRNA are important for escape. Finally, we found that the IL-6 3' UTR was also protected against mRNA degradation by the vhs endonuclease encoded by herpes simplex virus, despite the fact that its mechanism of mRNA targeting is distinct from SOX. These findings highlight how a multitude of RNA-protein interactions can impact endonuclease targeting, and identify new features underlying the regulation of the IL-6 mRNA.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25965334 PMCID: PMC4428876 DOI: 10.1371/journal.ppat.1004899
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Fig 3NCL binds the SRE in cells and contributes to IL-6 resistance.
(A) 293T cells were transfected with the indicated GFP reporter, cross linked in 1% formaldehyde for 10 min, and lysed. Lysates were subjected to RNA immunoprecipitation (RIP) with anti-NCL (or mock IP with IgG) and the co-purifying mRNA was quantified by RT-qPCR. Bars represent the fold enrichment over mock IP. ARF1, an a priori NCL non-target, was included as a negative control. (B) Western blot showing the expression levels of NCL in the RIP input or post IP. (C) 293TΔNCL cells were treated with doxycycline (DOX) to induce NCL depletion, then lysates were Western blotted for NCL or GAPDH as loading control. (D) 293TΔNCL were incubated +/- DOX, then subsequently transfected with the GFP 3’ IL-6 plasmid alone or together with a SOX expression plasmid. 24h later GFP mRNA levels were quantified by RT-qPCR. (E) DOX-treated 293TΔNCL cells were co-transfected with GFP-3’ IL-6 and the indicated WT or mutant NCL expression plasmid +/- SOX. 24h later GFP mRNA levels were quantified by RT-qPCR. (F) Western blot showing the expression levels of NCL or GAPDH as loading control.
SRE binding proteins.
| BCBL | 293T | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
| Official gene symbol | Uniprot accession number | Description | # of peptides | # of peptides | # of peptides | # of peptides | |
|
| P19338 | Nucleolin | 25 | 1 | 22 | 0 | |
|
| Q9H2U1 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | 8 | 0 | 13 | 0 | |
|
| Q9NZI8 | insulin-like growth factor 2 mRNA binding protein 1 | 5 | 0 | 12 | 0 | |
|
| Q53F64 | heterogeneous nuclear ribonucleoprotein A/B | 7 | 0 | 9 | 0 | |
|
| Q00839 | heterogeneous nuclear ribonucleoprotein U | 5 | 1 | 10 | 0 | |
|
| Q12771 | heterogeneous nuclear ribonucleoprotein D—also known as AUF1 | 8 | 0 | 6 | 1 | |
|
| Q9H6S0 | YTH domain containing 2 | 4 | 0 | 10 | 0 | |
|
| P06748 | Nucleophosmin | 7 | 0 | 6 | 0 | |
|
| Q6P158 | DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 | 5 | 0 | 8 | 0 | |
|
| Q7Z2W4 | Zinc finger CCCH-type antiviral 1 | 10 | 0 | 3 | 0 | |
|
| Q12905 | Interleukin enhancer-binding factor 2 | 5 | 0 | 7 | 0 | |
|
| P09651 | Heterogeneous nuclear ribonucleoprotein A1 | 5 | 1 | 5 | 0 | |
|
| O00425 | Insulin-like growth factor 2 mRNA-binding protein 3 | 6 | 0 | 4 | 0 | |
|
| O95793 | Staufen double-stranded RNA-binding protein 1 | 3 | 0 | 7 | 0 | |
|
| Q15717 | ELAV-like RNA binding protein 1—also known as HuR | 4 | 0 | 5 | 1 | |
|
| Q6ZN17 | Lin-28 homolog B | 5 | 0 | 4 | 0 | |
|
| Q96GM8 | Target of EGR1 member 1 | 4 | 0 | 5 | 0 | |
|
| B4E0W4 | cDNA FLJ61020, highly similar to Heterogeneous nuclear ribonucleoprotein D0 | 4 | 0 | 4 | 1 | |
|
| O75152 | Zinc finger CCCH-type containing 11A | 5 | 0 | 3 | 0 | |
|
| Q9NUQ6 | spermatogenesis associated, serine-rich 2-like | 7 | 0 | 1 | 0 | |
|
| O43660 | Pleiotropic regulator 1 | 3 | 0 | 4 | 0 | |
|
| P51991 | Heterogeneous nuclear ribonucleoprotein A3 | 4 | 0 | 3 | 0 | |
|
| Q96SI9 | Spermatid perinuclear RNA-binding protein | 3 | 0 | 4 | 0 | |
* proteins selected in this study for siRNA assay
** proteins previously identified as involved in IL-6 escape from SOX degradation [18]